Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PSEN2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of PSEN2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PSEN2 mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of PSEN2 mRNA | decreases expression | 17805973
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of PSEN2 mRNA | decreases expression | 12057914
|
D019810 |
Sodium Azide |
Sodium Azide results in decreased expression of PSEN2 mRNA | decreases expression | 12938025
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of PSEN2 mRNA | decreases expression | 17616710
|
D010126 |
Ozone |
Ozone results in decreased expression of PSEN2 mRNA | decreases expression | 16330353
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of PSEN2 mRNA | increases expression | 12807726
|
C121565 |
pifithrin |
pifithrin inhibits the reaction [PSEN2 protein mutant form promotes the reaction [Staurosporine results in increased activity of CASP3 protein]] | decreases reaction|increases activity|increases reaction | 12556443
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PSEN2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of PSEN2 mRNA | decreases expression | 18445702
|
C059514 |
resveratrol |
resveratrol results in decreased expression of PSEN2 protein | decreases expression | 11606380
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of PSEN2 mRNA | increases expression | 16772331
|
D019311 |
Staurosporine |
pifithrin inhibits the reaction [PSEN2 protein mutant form promotes the reaction [Staurosporine results in increased activity of CASP3 protein]] | decreases reaction|increases activity|increases reaction | 12556443
|
D019311 |
Staurosporine |
PSEN2 protein mutant form promotes the reaction [Staurosporine results in increased activity of CASP3 protein] | increases activity|increases reaction | 12556443
|
D019311 |
Staurosporine |
Staurosporine promotes the reaction [PSEN2 protein mutant form results in increased expression of APP protein] | increases expression|increases reaction | 12556443
|
D013654 |
Taurine |
Taurine results in decreased expression of PSEN2 mRNA | decreases expression | 16579726
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
3.49 | 6195326 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
pifithrin |
9.32 | 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
9.32 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.15 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.15 | 18653653 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.33 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
10.29 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.29 | 16434500 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.40 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.40 | 16183991 16162502 |
MESH:C536596 |
Alzheimer disease type 4 |
marker/mechanism |
|
| |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.52 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.56 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.64 | 17854713 16373670 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.29 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.17 | 19483382 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.33 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.70 | 16393696 17651959 17534123 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.70 | 18417511 17626835 18315731 19059883 15516495 16777450 14754758 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.79 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.82 | 16011737 16192424 16097048 18705752 16124888 16050911 15700767 10355542 16227642 15673190 15721981 3786805 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.92 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.92 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.92 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
8.92 | 17173139 20007298 1701930 20935162 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.92 | 16227395 19321006 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.64 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.72 | 16227395 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.49 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.60 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.79 | 6135515 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.29 | 4080065 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.85 | 19176532 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.17 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.46 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.77 | 16507316 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.06 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.79 | 16873680 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
6.10 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.99 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.11 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
9.11 | 19923254 16227642 10663392 17906064 19420014 16393943 14725611 16109766 19164858 12392966 11461765 17522070 11739529 11421492 12540782 12705907 12594235 16485898 19416960 16177239 11743745 11287661 15619225 19370779 11529661 19085960 14550746 17562736 19739265 12958197 2444490 10915739 12153990 14986274 18713872 18071297 10774834 16081117 16781746 11834606 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
9.11 | 19336974 10915739 3786805 19085960 6884620 15968718 17522070 2869522 15027814 21278145 7179309 16227642 3732212 7440962 15998439 16177239 10092053 11566570 4309450 7120509 9327722 6623471 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
9.11 | 9328219 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.04 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.87 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
11.87 | 8985016 |
MESH:D004487 |
Edema |
|
Staurosporine |
11.87 | 8273558 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.06 | 17872969 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.45 | 15821434 15328337 17637181 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.89 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.15 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.93 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.90 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.57 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.29 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.07 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.78 | 15547721 16704527 16805852 15623463 15150132 15547733 15878914 16510608 15264214 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
7.77 | 15959796 17595544 12795759 19224547 12631006 16239168 16045604 61145 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.77 | 19236843 20131406 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.04 | 11852909 9205823 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.50 | 18705752 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D006331 |
Heart Diseases |
|
pifithrin |
4.61 | 14766674 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.41 | 16366002 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.63 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
8.62 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.62 | 16221962 18467677 19772884 19176532 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.23 | 16876885 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.72 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.58 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.03 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.06 | 16873680 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.13 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.33 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
pifithrin |
12.09 | 19475672 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
12.09 | 17600658 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.49 | 17963957 9205823 17255318 12878042 17237260 |
MESH:D007249 |
Inflammation |
|
resveratrol |
5.49 | 16366677 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.61 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.65 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.66 | 17255318 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.21 | 15629191 12587719 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.00 | 16705839 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.59 | 16087638 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.75 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.68 | 17334410 17157831 11903743 16943688 16239168 11408273 16221502 17174718 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.68 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
5.07 | 17869086 14716496 16136751 18006644 17708605 18420326 17481882 17900296 18395914 15123356 15673190 18166357 18251166 20821823 12958196 15362042 15818738 16097048 12649538 12445418 18187930 18054572 18472094 15925388 17557913 18339082 16248980 15057751 13678700 16033810 16192424 15650968 17766677 17698563 12667390 15893842 12898905 12666154 17640975 10355542 17631135 18429990 12632514 14512876 17761835 17721639 18156304 18279442 18472332 12389079 18418968 12586293 15931870 14620537 12632512 16116963 17525996 12741479 18376398 16027843 18277467 15052691 18412020 11481614 16638106 15959796 14748882 15996030 15338365 17944888 17922224 17823541 15730626 14716833 12546737 18263696 18210741 16011737 15876570 18317297 17805973 18705752 12445421 18205269 17714472 18481824 16015684 17976157 14724832 15370692 17565644 18395095 12609069 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
5.07 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.07 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
5.07 | 15931870 15893842 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.52 | 16611625 19784758 12587719 12969438 11587558 19460945 16610002 19014921 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.52 | 15720792 16246199 15830285 16964402 17285989 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.52 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.21 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.50 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.50 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.36 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
14.36 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
14.36 | 21047994 8742319 19482888 19812893 19073162 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.36 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
14.36 | 19812893 20405173 19073162 19321006 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.96 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.96 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.96 | 18308698 2563599 6150874 17172636 1399818 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.39 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
9.38 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
9.38 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.09 | 7614698 8597069 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.33 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.89 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.30 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.13 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.37 | 17992120 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.61 | 19513568 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.41 | 17112576 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.17 | 10496685 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.49 | 17049120 16267019 16490592 17935668 14749477 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.92 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.78 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.78 | 17188708 16317513 17125593 16525036 17015251 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
4.03 | 17015251 17125593 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.81 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.53 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.91 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.96 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.04 | 8985016 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.43 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.43 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.43 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.46 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.41 | 17016548 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.29 | 17513867 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.41 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.50 | 16965848 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.17 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
11.27 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
11.27 | 18007984 18929643 18381685 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.65 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
4.23 | 16679765 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.63 | 15767336 17675339 17804756 17636462 17718901 16731767 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.56 | 12752131 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.65 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.61 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.61 | 16317513 17520802 15827377 16314181 17058453 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.75 | 10835634 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.99 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.99 | 3137016 16876388 4039156 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.87 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
3.04 | 8985016 15837718 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.32 | 12958204 17575124 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.51 | 16321402 |
MESH:D013345 |
Subarachnoid Hemorrhage |
|
pifithrin |
6.12 | 18364113 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.19 | 15821434 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.07 | 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.24 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.30 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.37 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.13 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.17 | 17044934 |
MESH:D020301 |
Vasospasm, Intracranial |
|
pifithrin |
5.67 | 18364113 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.34 | 17488730 |